Q1 2026 Indutrade AB Earnings Call Transcript
Key Points
- Order intake improved by 1% organically, with strong demand in medical technology, pharmaceuticals, energy, and parts of the process industry.
- Acquisitions contributed positively to sales, with a 5% increase from acquisitions compared to the previous quarter.
- The gross margin remained strong at 36%, indicating effective management of pricing and cost increases.
- Indutrade AB (IDTRY) acquired three companies, adding SEK625 million in annual revenue, with a strong acquisition pipeline.
- Operating cash flow was stable, and inventory levels were historically low, indicating efficient working capital management.
- Net sales were unchanged from last year, both in total and organically, due to currency movements and flat organic sales.
- EBITA margin decreased slightly to 13.3% from 13.6% last year, impacted by higher expenses and non-recurring downsizing costs.
- Sales in certain regions, such as Denmark and parts of Europe, declined due to lower demand in specific sectors.
- The company faced a weak start to the year, with January sales impacted by challenging weather and longer lead times in the order book.
- Earnings per share decreased by 4% due to lower operational results and higher interest rates.
Welcome to the Indutrade Q1 presentation for 2026. (Operator Instructions)
Now I will hand the conference over to CEO, Bo Annvik; and CFO, Patrik Johnson. Please go ahead.
Welcome and good morning on our behalf as well. As usual, let's start with some overall highlights from the quarter. We can begin with the demand situation. Order intake continued to improve versus last year. Organically, the order intake increased with plus 1%, with slightly more than half of the companies showing a positive order intake.
The strongest segments were medical technology and pharmaceuticals, energy and parts of the process industry. Net sales were unchanged from last year, both in total and organically. Contributions from acquisitions improved compared to the last quarters and was at a good level. EBITDA margin came in at 13.3%, in line with the underlying margin last year. And we will comment more on this further on in the presentation.
Operating cash flow was also in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
